Suchergebnisse - "Spinner, Christoph D"

PubPharm (263)

91

Evaluation of a multiplex PCR screening approach to identify community-acquired bacterial co-infections in COVID-19: a multicenter prospective cohort study of the German competence network of community-acquired pneumonia (CAPNETZ)

enthalten in: Infection | 2021

von Rothe, K. | Spinner, C. | Panning, M. | +8

92

Evaluation of a multiplex PCR screening approach to identify community-acquired bacterial co-infections in COVID-19: a multicenter prospective cohort study of the German competence network of community-acquired pneumonia (CAPNETZ)

enthalten in: Infection | 2021

von Rothe, K. | Spinner, C. | Panning, M. | +8

93

Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testing

enthalten in: Infection | 2021

von Würstle, S. | Spinner, C. | Voit, F. | +10

94

All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort

enthalten in: Infection | 2021

von Schons, M. | Caliebe, A. | Spinner, C. | +15

95

All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort

enthalten in: Infection | 2021

von Schons, M. | Caliebe, A. | Spinner, C. | +15

96

All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort

enthalten in: Infection | 2021

von Schons, M. | Caliebe, A. | Spinner, C. | +15

97

Reply : Beyond Viral Suppression

enthalten in: Open forum infectious diseases | 2021

von Spinner, C. | Wolf, E. | Boesecke, C.

98

Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution

enthalten in: Mathematical biosciences | 2021

von Kühn, M. | Abele, D. | Mitra, T. | +17

99

Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance

enthalten in: AIDS research and therapy | 2021

von Wolf, E. | Boesecke, C. | Balogh, A. | +9

100

Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance

enthalten in: AIDS research and therapy | 2021

von Wolf, E. | Boesecke, C. | Balogh, A. | +8